Completed
A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Type of Sarcoma:
Osteosarcoma
Drug:
Saracatinib and Placebo
Accrual Status:
Completed
Overall Study Principal Investigator:
Melinda Merchant, MD, PhD
Staff Clinician, Pediatric Oncology Branch
National Cancer Institute